| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00067 | 1 |